Respiratory Medicine
Volume 103, Issue 12 , Pages 1832-1837 , December 2009

Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD

  • H. Magnussen

      Affiliations

    • Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, 22927 Grosshansdorf, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 4102601151; fax: +49 4102601245.
  • ,
  • H. Watz

      Affiliations

    • Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, 22927 Grosshansdorf, Germany
  • ,
  • I. Zimmermann

      Affiliations

    • Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, 22927 Grosshansdorf, Germany
  • ,
  • S. Macht

      Affiliations

    • Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, 22927 Grosshansdorf, Germany
  • ,
  • R. Greguletz

      Affiliations

    • Almirall Sofotec GmbH, Benzstrasse 1, D-61352 Bad Homburg v. d. Hoehe, Germany
  • ,
  • M. Falques

      Affiliations

    • Almirall, R&D Centre, Laureà Miró 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
  • ,
  • D. Jarreta

      Affiliations

    • Almirall, R&D Centre, Laureà Miró 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
  • ,
  • E. Garcia Gil

      Affiliations

    • Almirall, R&D Centre, Laureà Miró 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain

Received 13 February 2009 ,Accepted 13 July 2009.

References 

  1. Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604
  2. Feddah MR, Brown KF, Gipps EM, Davies NM. In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates. J Pharm Pharm Sci. 2000;3:318–324
  3. Smith K, Chan H, Brown K. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers. J Aerosol Med. 1998;11:231–245
  4. Al Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?. Respir Med. 2007;101:2395–2401
  5. Janssens W, VandenBrande P, Hardeman E, et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J. 2008;31:78–83
  6. Global Strategy for the Diagnosis . Management and prevention of COPD, global initiative for chronic obstructive lung disease [GOLD]. Available from: http://www.goldcopd.com2007;
  7. de Koning JP, van der Mark ThW, Coenegracht PMJ, Tromp ThFJ, Frijlink HW. Effect of an external resistance to airflow on the inspiratory flow curve. Int J Pharm. 2002;234:257–266
  8. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part 1. The burden of obstructive lung disease (BOLD) initiative. J Tuberc Lung Dis. 2008;12:703–708
  9. Halbert RJ, Natoli JL, Gano A. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–532
  10. Srichana T, Martin GP, Marriott C. Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro. Eur J Pharm Sci. 1998;7:73–80
  11. Chodosh S, Flanders JS, Kesten S, Serby CW, Hochrainer D, Witek TJ. Effective delivery of particles with the handihaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med. 2001;14:309–315
  12. Newman S, Sutton D, Segarra R, Lamarca R, de Miquel G. Lung deposition of aclidinium bromide from genuair, a multidose dry powder inhaler. Respiration. 2009;Epub ahead of print
  13. Brand P, Meyer T, Weuthen T. Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease. J Clin Pharmacol. 2007;47:1335–1341

PII: S0954-6111(09)00239-X

doi: 10.1016/j.rmed.2009.07.006

Respiratory Medicine
Volume 103, Issue 12 , Pages 1832-1837 , December 2009